Advanced search
Publication Cover
Acta Oncologica Volume 44, 2005 - Issue 8
Journal homepage
549
Views
81
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group

Bengt Glimelius Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala, Sweden; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]
,
Olav Dahl Section of Oncology, Institute of Medicine, University of Bergen and Department of Oncology, Haukeland University Hospital, Bergen, Norway
,
Björn Cedermark Department of Surgery, Karolinska Institutet, Stockholm, Sweden
,
Anders Jakobsen Department of Oncology, Vejle Hospital, Vejle, Denmark
,
Søren M. Bentzen University of Wisconsin Medical School, Department of Human Oncology, Madison, Wisconsin, USA
,
Hans Starkhammar Department of Oncology, University Hospital, Linköping, Sweden
,
Henrik Grönberg Department of Oncology, University Hospital, Umeå, Sweden
,
Ragnar Hultborn Department of Oncology, Sahlgrenska University Hospital, Göteborg, Sweden
,
Maria Albertsson Department of Oncology, Malmö University Hospital, Malmö, Sweden
,
Lars Påhlman Department of Surgery, University Hospital, Uppsala, Sweden
&
Kjell-Magne Tveit Department of Oncology, Ullevål University Hospital, Oslo, Norway
 show all
Pages 904-912 | Received 04 Jul 2005, Published online: 28 Apr 2011

Citations (81)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Frida Lédel, Kristina Stenstedt, Marja Hallström, Peter Ragnhammar & David Edler. (2016) HER3 expression is correlated to distally located and low-grade colon cancer. Acta Oncologica 55:7, pages 875-880.
Read now
Laurids Ø. Poulsen, Camilla Qvortrup, Per Pfeiffer, Mette Yilmaz, Ursula Falkmer & Halfdan Sorbye. (2015) Review on adjuvant chemotherapy for rectal cancer – why do treatment guidelines differ so much?. Acta Oncologica 54:4, pages 437-446.
Read now
Olav Dahl & Frank Pfeffer. (2015) Twenty-five years with adjuvant chemotherapy for colon cancer – a continuous evolving concept. Acta Oncologica 54:1, pages 1-4.
Read now
Michael Wilhelmsen, Thomas Kring, Lars N. Jorgensen, Mogens Rørbæk Madsen, Per Jess, Orhan Bulut, Knud Thygesen Nielsen, Claus Lindbjerg Andersen & Hans Jørgen Nielsen. (2014) Determinants of recurrence after intended curative resection for colorectal cancer. Scandinavian Journal of Gastroenterology 49:12, pages 1399-1408.
Read now
Bjørn Steinar Nedrebø, Kjetil Søreide, Morten Tandberg Eriksen, Jan Terje Kvaløy, Jon Arne Søreide & Hartwig Kørner. (2013) Excess mortality after curative surgery for colorectal cancer changes over time and differs for patients with colon versus rectal cancer. Acta Oncologica 52:5, pages 933-940.
Read now
Gemma Gatta, Giulia Zigon, Tiiu Aareleid, Eva Ardanaz, Magdalena Bielska-Lasota, Jaume Galceran, Stanisław Góźdź, Timo Hakulinen, Carmen Martinez-Garcia, Ivan Plesko, Maja Primic Žakelj, Jadwiga Rachtan, Giovanna Tagliabue, Marina Vercelli & Jean Faivre. (2010) Patterns of care for European colorectal cancer patients diagnosed 1996–1998: A EUROCARE High Resolution Study. Acta Oncologica 49:6, pages 776-783.
Read now
Katarina Öhrling, David Edler, Marja Hallström & Peter Ragnhammar. (2010) Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer. Acta Oncologica 49:6, pages 797-804.
Read now
Kristoffer Derwinger, Karl Kodeda, Elinor Bexe-Lindskog & Helena Taflin. (2010) Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer. Acta Oncologica 49:1, pages 57-62.
Read now
Olav Dahl, Øystein Fluge, Erik Carlsen, Johan N. Wiig, Helge E. Myrvold, Barthold Vonen, Nina Podhorny, Ottar Bjerkeset, Tor Jack Eide, Tore B. Halvorsen & Kjell Magne Tveit. (2009) Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Acta Oncologica 48:3, pages 368-376.
Read now
David Edler, Katarina Öhrling, Marja Hallström, Mia Karlberg & Peter Ragnhammar. (2007) The number of analyzed lymph nodes – a prognostic factor in colorectal cancer. Acta Oncologica 46:7, pages 975-981.
Read now

Articles from other publishers (71)

Zhi-Zhong Xiong, Ming-Hao Xie, Xian-Zhe Li, Long-Yang Jin, Feng-Xiang Zhang, Shi Yin, Hua-Xian Chen & Lei Lian. (2023) Risk factors for postoperative recurrence in patients with stage II colorectal cancer. BMC Cancer 23:1.
Crossref
Kheng-Seong Ng, Charles Chan, Matthew John Francis Xavier Rickard, Anil Keshava, Peter Stewart & Pierre Henri Chapuis. (2023) The use of adjuvant chemotherapy is not associated with recurrence or cancer-specific death following curative resection for stage III rectal cancer: a competing risks analysis. World Journal of Surgical Oncology 21:1.
Crossref
Per Albertsson, Tom Bäck, Karin Bergmark, Andreas Hallqvist, Mia Johansson, Emma Aneheim, Sture Lindegren, Chiara Timperanza, Knut Smerud & Stig Palm. (2023) Astatine-211 based radionuclide therapy: Current clinical trial landscape. Frontiers in Medicine 9.
Crossref
A. V. Shabunin, D. N. Grekov, Z. A. Bagateliya, V. M. Kulushev, N. Yu. Sokolov, A. G. Minenkova, S. S. Lebedev & M. S. Lebedko. (2022) Perioperative chemotherapy in the treatment of locally advanced forms of colon cancer: literature review. Pelvic Surgery and Oncology 12:4, pages 52-59.
Crossref
Sarah B. Jochum, Adan Z. Becerra, Yanyu Zhang, Dana M. Hayden, Theodore J. Saclarides & Anuradha R. Bhama. (2021) Keep Them on the Table: Outcomes Are Improved After Minimally Invasive Colectomy Despite Longer Operative Times in Patients With High-Risk Colon Cancer. Diseases of the Colon & Rectum 65:9, pages 1143-1152.
Crossref
Soo-Yoon Sung, Sung Hwan Kim, Hong Seok Jang, Jin Ho Song, Songmi Jeong, Ji-Han Jung & Jong Hoon Lee. (2022) Pathologic Implications of Radial Resection Margin and Perineural Invasion to Adjuvant Chemotherapy after Preoperative Chemoradiotherapy and Surgery for Rectal Cancer: A Multi-Institutional and Case-Matched Control Study. Cancers 14:17, pages 4112.
Crossref
Aditya Bernard Dharmaji, Mappincara, Muhammad Ihwan Kusuma, Samuel Sampetoding, Warsinggih, Ibrahim Labeda, Julianus Aboyaman Uwuratuw, Erwin Syarifuddin, Joko Hendarto & Muhammad Faruk. (2021) Analysis of colorectal cancer survival rate at a single institution. Medicina Clínica Práctica 4, pages 100232.
Crossref
Mercedes Herrera, Artur Mezheyeuski, Lisa Villabona, Sara Corvigno, Carina Strell, Christian Klein, Gabriele Hölzlwimmer, Bengt Glimelius, Giuseppe Masucci, Tobias Sjöblom & Arne Östman. (2020) Prognostic Interactions between FAP+ Fibroblasts and CD8a+ T Cells in Colon Cancer. Cancers 12:11, pages 3238.
Crossref
Bengt Glimelius & Erik Osterman. (2020) Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients. Cancers 12:8, pages 2289.
Crossref
Bengt Glimelius. (2020) Adjuvant chemotherapy in rectal cancer: state of the art and future perspectives. Current Opinion in Oncology 32:4, pages 377-383.
Crossref
Sanghoon Kim, Sung Uk Bae, Seong Kyu Baek & Woon Kyung Jeong. (2020) Comparing the initiation of adjuvant chemotherapy after robotic and laparoscopic colon cancer surgeries: A case-controlled study with propensity score matching. Korean Journal of Clinical Oncology 16:1, pages 9-17.
Crossref
G. Bregni, T. Akin Telli, S. Camera, A. Deleporte, L. Moretti, A.M. Bali, G. Liberale, S. Holbrechts, A. Hendlisz & F. Sclafani. (2020) Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice. Cancer Treatment Reviews 83, pages 101948.
Crossref
Artur Mezheyeuski, Ina Hrynchyk, Mercedes Herrera, Mia Karlberg, Eric Osterman, Peter Ragnhammar, David Edler, Anna Portyanko, Fredrik Ponten, Tobias Sjöblom, Bengt Glimelius & Arne Östman. (2019) Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer. British Journal of Cancer 121:4, pages 303-311.
Crossref
P. H. Chapuis, E. Bokey, C. Chan, A. Keshava, M. J. F. X. Rickard, P. Stewart, C. J. Young & O. F. Dent. (2018) Recurrence and cancer‐specific death after adjuvant chemotherapy for Stage III colon cancer . Colorectal Disease 21:2, pages 164-173.
Crossref
Hasan Jalaeikhoo, Ahmad Khajeh-Mehrizi, Mohammad Zokaasadi, Mohsen Rajaeinejad, Seied Asadollah Mousavi, Mohammad Vaezi, Hosein Kamranzadeh Fumani, Manoutchehr Keyhani, Kamran Alimoghaddam & Ardeshir Ghavamzadeh. (2018) Sixteen Years of Experience with the Treatment of Advanced Colorectal Cancer in Iran; A Report from Three Institutions. Middle East Journal of Digestive Diseases 10:3, pages 160-168.
Crossref
Francesco Santullo, Alberto Biondi, Ferdinando C.M. Cananzi, Valeria Fico, Flavio Tirelli, Riccardo Ricci, Gianluca Rizzo, Claudio Coco, Claudio Mattana, Domenico D'Ugo & Roberto Persiani. (2018) Tumor size as a prognostic factor in patients with stage IIa colon cancer. The American Journal of Surgery 215:1, pages 71-77.
Crossref
Alix Marhic, Jean-François Tremblay, Rachid Kaci, Thierry André, Clarisse Eveno & Marc Pocard. (2017) Molecular analysis of sentinel lymph node in colon carcinomas by one-step nucleic acid amplification (OSNA) reduces time to adjuvant chemotherapy interval. Digestive and Liver Disease 49:8, pages 924-928.
Crossref
Aslam Ejaz, Leigh Casadaban & Ajay V. Maker. (2017) Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis. Journal of Surgical Research 215, pages 12-20.
Crossref
Sara Corvigno, Magnus Frödin, G Bea A Wisman, Hans W Nijman, Ate GJ Van der Zee, Karin Jirström, Björn Nodin, Ina Hrynchyk, David Edler, Peter Ragnhammar, Martin Johansson, Hanna Dahlstrand, Artur Mezheyeuski & Arne Östman. (2017) Multi‐parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour‐type‐specific stroma phenotypes and a novel vascular biomarker. The Journal of Pathology: Clinical Research 3:3, pages 214-224.
Crossref
Jung‐A Yun, Hee Cheol Kim, Seok‐Hyung Kim, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee & Ho‐Kyung Chun. (2014) Prognostic significance of perineural invasion in stage IIA colon cancer . ANZ Journal of Surgery 86:12, pages 1007-1013.
Crossref
Smrity Upadhyay, Sumit Dahal, Vijaya Raj Bhatt, Nabin Khanal & Peter T. Silberstein. (2015) Chemotherapy use in stage III colon cancer: a National Cancer Database analysis. Therapeutic Advances in Medical Oncology 7:5, pages 244-251.
Crossref
Bobby V M Dasari, Sandro Pasquali, Ravinder S Vohra, Andrew M Smith, Mark A Taylor, Robert P Sutcliffe, Paolo Muiesan, Keith J Roberts, John Isaac & Darius F Mirza. (2015) Extended Versus Standard Lymphadenectomy for Pancreatic Head Cancer: Meta-Analysis of Randomized Controlled Trials. Journal of Gastrointestinal Surgery 19:9, pages 1725-1732.
Crossref
In Ja Park, Dae Yong Kim, Hee Cheol Kim, Nam Kyu Kim, Hyeong-Rok Kim, Sung-Bum Kang, Gyu-Seog Choi, Kang Young Lee, Seon-Hahn Kim, Seung Taek Oh, Seok-Byung Lim, Jin Cheon Kim, Jae Hwan Oh, Sun Young Kim, Woo Yong Lee, Jung Bok Lee & Chang Sik Yu. (2015) Role of Adjuvant Chemotherapy in ypT0-2N0 Patients Treated with Preoperative Chemoradiation Therapy and Radical Resection for Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics 92:3, pages 540-547.
Crossref
Kim F. RhoadsManali I. PatelYifei MaLaura A. Schmidt. (2015) How Do Integrated Health Care Systems Address Racial and Ethnic Disparities in Colon Cancer?. Journal of Clinical Oncology 33:8, pages 854-860.
Crossref
Shahab Hajibandeh & Shahin Hajibandeh. (2015) Systematic Review: Adjuvant Chemotherapy for Locally Advanced Rectal Cancer with respect to Stage of Disease. International Scholarly Research Notices 2015, pages 1-10.
Crossref
Woon Kyung JeongJe-Wook ShinSeong Kyu Baek. (2015) Oncologic outcomes of early adjuvant chemotherapy initiation in patients with stage III colon cancer. Annals of Surgical Treatment and Research 89:3, pages 124.
Crossref
Marlies S. Reimers, Peter J. K. Kuppen, Mark Lee, Margarita Lopatin, Haluk Tezcan, Hein Putter, Kim Clark-Langone, Gerrit Jan Liefers, Steve Shak & Cornelis J. H. van de Velde. (2014) Validation of the 12-Gene Colon Cancer Recurrence Score as a Predictor of Recurrence Risk in Stage II and III Rectal Cancer Patients. JNCI: Journal of the National Cancer Institute 106:11.
Crossref
Fang Xu, Alfred A. Rimm, Pingfu Fu, Smitha S. Krishnamurthi & Gregory S. Cooper. (2014) The Impact of Delayed Chemotherapy on Its Completion and Survival Outcomes in Stage II Colon Cancer Patients. PLoS ONE 9:9, pages e107993.
Crossref
R. Glynne-Jones, N. Counsell, P. Quirke, N. Mortensen, A. Maraveyas, H.M. Meadows, J. Ledermann & D. Sebag-Montefiore. (2014) Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control. Annals of Oncology 25:7, pages 1356-1362.
Crossref
Mehmet Artac, Nazim Serdar Turhal, Murat Kocer, Bulent Karabulut, Hakan Bozcuk, Suayip Yalcin, Mustafa Karaagac, Seyda Gündüz, Nalan Isik & Kazim Uygun. (2018) Do High-risk Features Support the Use of Adjuvant Chemotherapy in Stage II Colon Cancer? A Turkish Oncology Group Study. Tumori Journal 100:2, pages 143-148.
Crossref
F. Lédel, M. Hallström, P. Ragnhammar, K. Öhrling & D. Edler. (2014) HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome. European Journal of Cancer 50:3, pages 656-662.
Crossref
Anita Sveen, Arild Nesbakken, Trude H. Ågesen, Marianne G. Guren, Kjell M. Tveit, Rolf I. Skotheim & Ragnhild A. Lothe. (2013) Anticipating the Clinical Use of Prognostic Gene Expression–Based Tests for Colon Cancer Stage II and III: Is Godot Finally Arriving?. Clinical Cancer Research 19:24, pages 6669-6677.
Crossref
B. Glimelius. (2013) Adjuvant chemotherapy. European Journal of Cancer Supplements 11:2, pages 72-79.
Crossref
Katarina Öhrling, Mia Karlberg, David Edler, Marja Hallström & Peter Ragnhammar. (2013) A Combined Analysis of Mismatch Repair Status and Thymidylate Synthase Expression in Stage II and III Colon Cancer. Clinical Colorectal Cancer 12:2, pages 128-135.
Crossref
Marko Kornmann, Ludger Staib, Thomas Wiegel, Martina Kron, Doris Henne-Bruns, Karl-Heinrich Link & Andrea Formentini. (2013) Long-Term Results of 2 Adjuvant Trials Reveal Differences in Chemosensitivity and the Pattern of Metastases Between Colon Cancer and Rectal Cancer. Clinical Colorectal Cancer 12:1, pages 54-61.
Crossref
Sune Høirup Petersen, Henrik Harling, Lene Tschemerinsky Kirkeby, Peer Wille-Jørgensen & Simone Mocellin. (2012) Postoperative adjuvant chemotherapy in rectal cancer operated for cure.. Cochrane Database of Systematic Reviews.
Crossref
Xiaojian Wu, Junxiao Zhang, Xiaosheng He, Chenliang Wang, Lei Lian, Huanliang Liu, Jianping Wang & Ping Lan. (2012) Postoperative Adjuvant Chemotherapy for Stage II Colorectal Cancer: A Systematic Review of 12 Randomized Controlled Trials. Journal of Gastrointestinal Surgery 16:3, pages 646-655.
Crossref
Nicholas ZdenkowskiStanley Chen, Andre WesthuizenStephen Ackland. (2012) Curative Strategies for Liver Metastases from Colorectal Cancer: A Review. The Oncologist 17:2, pages 201-211.
Crossref
Bengt Glimelius & Peter Nygren. 2012. Multidisciplinary Management of Rectal Cancer. Multidisciplinary Management of Rectal Cancer 217 225 .
Alexander Stein, Sonja Hiemer & Hans-Joachim Schmoll. (2011) Adjuvant Therapy for Early Colon Cancer. Drugs 71:17, pages 2257-2275.
Crossref
Chandrakumar Shanmugam, Robert B Hines, Nirag C Jhala, Venkat R Katkoori, Bin Zhang, James A PoseyJrJr, Harvey L Bumpers, William E Grizzle, Isam E Eltoum, Gene P Siegal & Upender Manne. (2011) Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer. Journal of Hematology & Oncology 4:1.
Crossref
Xiao-Gang Shen, Cun Wang, Yuan Li, Bin Zhou, Bin Xu, Lie Yang, Zong-Guang Zhou & Xiao-Feng Sun. (2011) Downregulation of caspase-10 predicting poor survival after resection of stage II colorectal cancer. International Journal of Colorectal Disease 26:12, pages 1519-1524.
Crossref
Efrat Dotan & Steven J. Cohen. (2011) Challenges in the Management of Stage II Colon Cancer. Seminars in Oncology 38:4, pages 511-520.
Crossref
Ulas Darda Bayraktar, Emerson Chen, Soley Bayraktar, Laurence R. Sands, Floriano Marchetti, Alberto Jose Montero & Caio Max S. Rocha‐Lima. (2010) Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma?. Cancer 117:11, pages 2364-2370.
Crossref
Sun Hee JeeSun Mi MoonUi Sup ShinHoe Min YangDae-Yong Hwang. (2011) Effectiveness of Adjuvant Chemotherapy with 5-FU/Leucovorin and Prognosis in Stage II Colon Cancer. Journal of the Korean Society of Coloproctology 27:6, pages 322.
Crossref
X.‐G. Shen, C. Wang, Y. Li, L. Wang, B. Zhou, B. Xu, X. Jiang, Z.‐G. Zhou & X.‐F. Sun. (2010) Downregulation of caspase‐9 is a frequent event in patients with stage II colorectal cancer and correlates with poor clinical outcome. Colorectal Disease 12:12, pages 1213-1218.
Crossref
J.W.T. Dekker, K.C. Peeters, H. Putter, A.L. Vahrmeijer & C.J.H. van de Velde. (2010) Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification. European Journal of Surgical Oncology (EJSO) 36:12, pages 1180-1186.
Crossref
M Kornmann, L Staib, T Wiegel, E-D Kreuser, M Kron, W Baumann, D Henne-Bruns & K-H Link. (2010) Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α. British Journal of Cancer 103:8, pages 1163-1172.
Crossref
Shahid Ahmed, Imran Ahmad, Tong Zhu, Florence P. Arnold, Ghadeer Faiz Anan, Amer Sami, Sunil K. Yadav, Riaz Alvi & Kamal Haider. (2010) Early Discontinuation but Not the Timing of Adjuvant Therapy Affects Survival of Patients With High-Risk Colorectal Cancer: A Population-Based Study. Diseases of the Colon & Rectum 53:10, pages 1432-1438.
Crossref
Kristoffer Derwinger, Göran Carlsson & Tor Ekman. (2010) Defining stage III disease in colorectal cancer—aspects on treatment and evaluation of survival. Journal of Surgical Oncology 102:5, pages 424-427.
Crossref
B. Glimelius. (2010) Adjuvant chemotherapy in rectal cancer—an issue or a nonissue?. Annals of Oncology 21:9, pages 1739-1741.
Crossref
K. Bujko, R. Glynne-Jones & M. Bujko. (2010) Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials. Annals of Oncology 21:9, pages 1743-1750.
Crossref
Paula Manchon Walsh, Josep M. Borràs, Tàrsila Ferro & Josep Alfons Espinàs. (2010) Colorectal cancer OncoGuia. Clinical and Translational Oncology 12:3, pages 188-210.
Crossref
Pierre H. Chapuis, E. Leslie Bokey, Stephen Clarke, Philip Beale & Owen F. Dent. (2009) Adjuvant chemotherapy for stage C colonic cancer in a multidisciplinary setting. ANZ Journal of Surgery 79:10, pages 685-692.
Crossref
Hae Ran Yun, Hee Cheol Kim, Woo Yong Lee, Yong Beom Cho, Seong Hyeon Yun & Ho-Kyung Chun. (2009) The necessity of chemotherapy in T3N0M0 colon cancer without risk factors. The American Journal of Surgery 198:3, pages 354-358.
Crossref
David Edler, Kristina Stenstedt, Katarina Öhrling, Marja Hallström, Maria Karlgren, Magnus Ingelman-Sundberg & Peter Ragnhammar. (2009) The expression of the novel CYP2W1 enzyme is an independent prognostic factor in colorectal cancer – A pilot study. European Journal of Cancer 45:4, pages 705-712.
Crossref
Seung Ho ShinSun-Il LeeDong-Jin ChoiSi-Uk WooJin KimByung-Wook MinHong-Young MoonSeon Hahn Kim. (2009) Safety of Early Chemotherapy after a Laparoscopic Colorectal Cancer Resection: A Case-Control Study. Journal of the Korean Society of Coloproctology 25:6, pages 429.
Crossref
Charlotte F. J. M. Peeters, Robert M. W. de Waal, Theo Wobbes & Theo J. M. Ruers. (2008) Metastatic Dormancy Imposed by the Primary Tumor: Does it Exist in Humans?. Annals of Surgical Oncology 15:11, pages 3308-3315.
Crossref
Alvaro Figueredo, Megan E Coombes & Som Mukherjee. (2008) Adjuvant Therapy for completely resected Stage II Colon Cancer. Cochrane Database of Systematic Reviews 2010:1.
Crossref
K. Derwinger, G. Carlsson & B. Gustavsson. (2008) A study of lymph node ratio as a prognostic marker in colon cancer. European Journal of Surgical Oncology (EJSO) 34:7, pages 771-775.
Crossref
Y. Bécouarn, S. Guillo, P. Artru, E. Assenat, J. -F. Bosset, T. Conroy, E. Françis, J. Taïeb & E. Touboul. (2008) Synthèse méthodique: intérêt de la chimiothérapie périopératoire dans la prise en charge des patients atteints d’un adénocarcinome du rectum résécable d’emblée (rapport abrégé)Systematic review: value of perioperative chemotherapy in the management of resectable rectal adenocarcinoma (brief report). Oncologie 10:3, pages 226-232.
Crossref
Å. Berglund, B. Cedermark & B. Glimelius. (2008) Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III?. Annals of Oncology 19:2, pages 400-402.
Crossref
Rob Glynne-Jones, Pawan Mathur, Colin Elton & Matthew L. Train. (2007) Multimodal treatment of rectal cancer. Best Practice & Research Clinical Gastroenterology 21:6, pages 1049-1070.
Crossref
QUASAR Collaborative Group. (2007) Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. The Lancet 370:9604, pages 2020-2029.
Crossref
Fangying Xu, Fenjuan Wang, Meijuan Di, Qiong Huang, Min Wang, Hu Hu, Yisen Jin, Jiankang Dong & Maode Lai. (2007) Classification Based on the Combination of Molecular and Pathologic Predictors is Superior to Molecular Classification on Prognosis in Colorectal Carcinoma. Clinical Cancer Research 13:17, pages 5082-5088.
Crossref
Jean-Pierre Gérard & Eric François. (2007) Update on neoadjuvant strategies for rectal cancer patients. Current Colorectal Cancer Reports 3:3, pages 158-165.
Crossref
R. Glynne-Jones, H. Meadows & W. Wood. (2007) Chemotherapy or No Chemotherapy in Clear Margins after Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: CHRONICLE. A Randomised Phase III Trial of Control vs. Capecitabine plus Oxaliplatin. Clinical Oncology 19:5, pages 327-329.
Crossref
A Sjövall, T Holm, T Singnomklao, F Granath, B Glimelius & B Cedermark. (2007) Colon cancer management and outcome in relation to individual hospitals in a defined population. British Journal of Surgery 94:4, pages 491-499.
Crossref
Annika Sjövall, Fredrik Granath, Björn Cedermark, Bengt Glimelius & Torbjörn Holm. (2006) Loco-regional Recurrence from Colon Cancer: A Population-based Study. Annals of Surgical Oncology 14:2, pages 432-440.
Crossref
Morten T. Eriksen, Arne Wibe, Jon Haffner & Johan N. Wiig. (2007) Prognostic Groups in 1,676 Patients with T3 Rectal Cancer Treated without Preoperative Radiotherapy. Diseases of the Colon & Rectum 50:2, pages 156-167.
Crossref
P. Pfeiffer, J.P. Mortensen, B. Bjerregaard, L. Eckhoff, K. Schønnemann, E. Sandberg, K. Aabo & A. Jakobsen. (2006) Patient preference for oral or intravenous chemotherapy: A randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer. European Journal of Cancer 42:16, pages 2738-2743.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.